In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia

J Clin Invest. 1996 May 15;97(10):2377-83. doi: 10.1172/JCI118681.


Gene products of all three distinct nitric oxide synthases are present in the mammalian kidney. This mosaic topography of nitric oxide synthase (NOS) isoforms probably reflects distinct functional role played by each enzyme. While nitric oxide (NO) is cytotoxic to isolated renal tubules, inhibition of NO production in vivo invariably results in the aggravation of renal dysfunction in various models of acute renal failure. We reasoned that the existing ambiguity on the role of nitric oxide in acute renal failure is in part due to the lack of selective NOS inhibitors. Phosphorothioated derivatives of antisense oligodeoxynucleotides targeting a conserved sequence within the open reading frame of the cDNA encoding the inducible NOS (iNOS) were designed to produce a selective knock-down of this enzyme. In vivo use of these antisense constructs attenuated acute renal failure in rats subjected to renal ischemia. This effect was due, at least in part, to the rescue of tubular epithelium from lethal injury. Application of antisense constructs did not affect endothelial NOS, as evidenced by a spared NO release after the infusion of bradykinin during in vivo monitoring with an NO-selective microelectrode. In conclusion, the data provide direct evidence for the cytotoxic effects of NO produced via iNOS in the course of ischemic acute renal failure, and offer a novel method to selectively prevent the induction of this enzyme.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Ischemia / metabolism*
  • Kidney / blood supply*
  • Male
  • Molecular Sequence Data
  • Nitric Oxide / biosynthesis
  • Nitric Oxide Synthase / physiology*
  • Oligonucleotides, Antisense / pharmacology*
  • Rats
  • Rats, Sprague-Dawley


  • Oligonucleotides, Antisense
  • Nitric Oxide
  • Nitric Oxide Synthase